{
    "ticker": "NDRA",
    "name": "Endra Life Sciences Inc.",
    "description": "Endra Life Sciences Inc. is a pioneering medical technology company focused on enhancing the visualization of tissues and organs for improved patient care. Founded in 2007 and headquartered in Ann Arbor, Michigan, Endra is dedicated to revolutionizing the way clinicians visualize and assess tissue health, particularly in the field of liver disease. The company's flagship product, TAEUS\u2122, is a novel imaging technology that combines ultrasound and proprietary software to provide clinicians with enhanced real-time imaging of liver fat content, a crucial metric in the diagnosis and management of non-alcoholic fatty liver disease (NAFLD) and other liver conditions. This innovative approach aims to improve patient outcomes by enabling more accurate diagnosis and monitoring, ultimately reducing the need for invasive procedures such as biopsies. Endra's commitment to advancing medical imaging aligns with its mission to improve the quality of life for patients worldwide. The company is also exploring additional applications of its technology across various medical fields, positioning itself as a leader in the next generation of diagnostic imaging solutions.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Ann Arbor, Michigan, USA",
    "founded": "2007",
    "website": "https://www.endrainc.com",
    "ceo": "Francois Michelon",
    "social_media": {
        "twitter": "https://twitter.com/EndraLife",
        "linkedin": "https://www.linkedin.com/company/endralifesciences/"
    },
    "investor_relations": "https://www.endrainc.com/investor-relations",
    "key_executives": [
        {
            "name": "Francois Michelon",
            "position": "CEO"
        },
        {
            "name": "Michael T. McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Imaging Technology",
            "products": [
                "TAEUS\u2122"
            ]
        }
    ],
    "seo": {
        "meta_title": "Endra Life Sciences Inc. | Innovative Medical Imaging Technology",
        "meta_description": "Explore Endra Life Sciences Inc., a leader in medical imaging technology focused on improving liver disease diagnosis through innovative ultrasound solutions.",
        "keywords": [
            "Endra Life Sciences",
            "Medical Technology",
            "Imaging Solutions",
            "Liver Disease",
            "TAEUS",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Endra Life Sciences focus on?",
            "answer": "Endra Life Sciences focuses on innovative medical imaging technologies for enhanced visualization of tissues, particularly for liver health."
        },
        {
            "question": "Who is the CEO of Endra Life Sciences?",
            "answer": "Francois Michelon is the CEO of Endra Life Sciences Inc."
        },
        {
            "question": "Where is Endra Life Sciences headquartered?",
            "answer": "Endra Life Sciences is headquartered in Ann Arbor, Michigan, USA."
        },
        {
            "question": "What is TAEUS\u2122?",
            "answer": "TAEUS\u2122 is Endra's flagship imaging technology that provides enhanced ultrasound imaging of liver fat content."
        },
        {
            "question": "When was Endra Life Sciences founded?",
            "answer": "Endra Life Sciences was founded in 2007."
        }
    ],
    "competitors": [
        "GE",
        "MDT",
        "ZBH"
    ],
    "related_stocks": [
        "AAPL",
        "AMZN",
        "MSFT",
        "GOOGL"
    ]
}